BUSINESS

• Daiichi Sankyo Pushes Global HR Revamp, Adopts Job-Based Scheme
  May 13, 2025

• Shionogi Nets Record Earnings for 3rd Consecutive Year on Overseas Expansion
  May 13, 2025

• Toho Launches Specialty Drug Home Delivery Service with Vyvdura
  May 13, 2025

• Bayer Files Eylea 8 mg for Macular Edema following RVO in Japan
  May 13, 2025

• Lusefi Filed for Pediatric Use in Japan: Taisho
  May 13, 2025

• J&J Taps Chris Rieger to Lead Japan Pharma Business
  May 13, 2025

• Shionogi, Cilcare Ink Research Collab on Novel Hearing Loss Drugs
  May 12, 2025

• Canaglu Now Available in Thailand: Mitsubishi Tanabe
  May 12, 2025

• Keytruda Tops Japan Drug Sales Ranking for 19th Month: Encise
  May 12, 2025

• Japan Ethical Drug Sales Up 5.2% in March: Crecon
  May 12, 2025

• Otsuka, Keio Join Hands to Facilitate “Social Implementation” of Psychedelics
  May 12, 2025

• Takeda on Course to Stable Growth as Late-Stage Assets Near Market
  May 9, 2025

• Lilly Japan Scores Double-Digit Growth for 2nd Year as Mounjaro Delivers
  May 9, 2025

• Ono’s Profits Slide Over 60% as Deciphera Buyout Costs Swell
  May 9, 2025

• Kyowa Kirin Announces Another Buyout Package; Job Cut Target Not Set
  May 8, 2025

• Pfizer Seeks Wider Label for PARP Inhibitor Talzenna in Japan
  May 8, 2025

• Cheplapharm to Take Over Japan MA for Fuji Pharma’s Vesanoid
  May 8, 2025

• Medipal/JCR’s MPS IIIB Therapy Snags Orphan Tag in US
  May 8, 2025

• Enhertu Hits Main Goal in Neoadjuvant Trial for Breast Cancer
  May 8, 2025

• Shionogi to Buy Torii in 160 Billion Yen Deal, JT Pulls Plug on Pharma Biz
  May 8, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 42
• 43
• 44
• 45
• 46
• 47
• 48
• 49
• 50
• …
• Next ›
• 最終 »